BOULDER, Colo., Sept. 10, 2015 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will present at the Morgan Stanley Global Healthcare Conference in New York. The public is welcome to participate in the conference through a webcast on the Array BioPharma website.
Event: | Morgan Stanley Global Healthcare Conference |
Presenter: | Ron Squarer, Chief Executive Officer |
Date: | Thursday, September 17, 2015 |
Time: | 2:05 p.m. Eastern Time |
Webcast: |
About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Six registration studies are currently advancing related to three cancer drugs. These programs include binimetinib (MEK162 / wholly-owned), encorafenib (LGX818 / wholly-owned) and selumetinib (AstraZeneca). For more information on Array, please go to www.arraybiopharma.com.
CONTACT: | Tricia Haugeto |
Array BioPharma Inc. | |
303-386-1193 | |
Logo - http://photos.prnewswire.com/prnh/20121029/LA02195LOGO
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/array-biopharma-to-present-at-the-morgan-stanley-global-healthcare-conference-300141238.html
SOURCE Array BioPharma
Help employers find you! Check out all the jobs and post your resume.
